{"id":474419,"date":"2026-02-12T05:31:07","date_gmt":"2026-02-12T05:31:07","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/474419\/"},"modified":"2026-02-12T05:31:07","modified_gmt":"2026-02-12T05:31:07","slug":"novo-nordisks-wegovy-launch-faces-competition-shares-drop-tradingview-news","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/474419\/","title":{"rendered":"Novo Nordisk&#8217;s Wegovy launch faces competition; shares drop \u2014 TradingView News"},"content":{"rendered":"<p>\tKey facts: Novo Nordisk&#8217;s Wegovy launch faces competition; shares drop \u2014 TradingView News<\/p>\n<p>\tDeutsche Bank&#8217;s Emmanuel Papadakis highlighted Novo Nordisk&#8217;s potential in the obesity market with Wegovy&#8217;s strong launch, despite a target price cut. Shares fell 2.4% to 307.55 kroner.<a href=\"https:\/\/www.tradingview.com\/news\/DJN_DN20260211002965:0\" target=\"_blank\" data-exclude-from-news-link-analytics=\"true\" class=\"tag-Jww2aqrB tag-zVPYJd3B xxsmall-zVPYJd3B square-zVPYJd3B interactive-zVPYJd3B apply-overflow-tooltip apply-overflow-tooltip--allow-text apply-overflow-tooltip--check-children\" rel=\"nofollow noopener\">1<\/a>Novo Nordisk plans to expand the distribution of its weight-loss medication Wegovy by introducing vials, enhancing accessibility for consumers.<a href=\"https:\/\/www.tradingview.com\/news\/reuters.com,2026:newsml_FWN3Z71JP:0\" target=\"_blank\" data-exclude-from-news-link-analytics=\"true\" class=\"tag-Jww2aqrB tag-zVPYJd3B xxsmall-zVPYJd3B square-zVPYJd3B interactive-zVPYJd3B apply-overflow-tooltip apply-overflow-tooltip--allow-text apply-overflow-tooltip--check-children\" rel=\"nofollow noopener\">2<\/a>Novo Nordisk faces heightened competition in the obesity-drug market as Eli Lilly has launched its weight-loss drug Zepbound in 2024, accompanied by a price reduction and expanded online availability.<a href=\"https:\/\/www.tradingview.com\/news\/reuters.com,2026:newsml_L4N3Z7259:0\" target=\"_blank\" data-exclude-from-news-link-analytics=\"true\" class=\"tag-Jww2aqrB tag-zVPYJd3B xxsmall-zVPYJd3B square-zVPYJd3B interactive-zVPYJd3B apply-overflow-tooltip apply-overflow-tooltip--allow-text apply-overflow-tooltip--check-children\" rel=\"nofollow noopener\">3<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Key facts: Novo Nordisk&#8217;s Wegovy launch faces competition; shares drop \u2014 TradingView News Deutsche Bank&#8217;s Emmanuel Papadakis highlighted&hellip;\n","protected":false},"author":2,"featured_media":366708,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[64,63,137,490],"class_list":["post-474419","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-au","tag-australia","tag-health","tag-medication"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/474419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=474419"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/474419\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/366708"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=474419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=474419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=474419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}